Bisphosphonates: beyond prevention of bon... [J Natl Cancer Inst. 2011] - PubMed

Save items

loading

Related citations in PubMed

Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. [J Natl Cancer Inst. 2011]
Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.
Monsees GM, Malone KE, Tang MT, Newcomb PA, Li CI. J Natl Cancer Inst. 2011 Dec 7; 103(23):1752-60. Epub 2011 Oct 21.
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. [J Natl Cancer Inst. 2011]
Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sørensen HT, Lash TL. J Natl Cancer Inst. 2011 Oct 5; 103(19):1461-8. Epub 2011 Aug 2.
Re: The association between statins and cancer incidence in a veterans population. [J Natl Cancer Inst. 2008]
Re: The association between statins and cancer incidence in a veterans population.
Ravnskov U. J Natl Cancer Inst. 2008 Jul 2; 100(13):972-3; author reply 973-4. Epub 2008 Jun 24.
Review The anti-tumor effect of bisphosphonates ABCSG-12, ZO-FAST and more ... [Crit Rev Oncol Hematol. 2010]
Review The anti-tumor effect of bisphosphonates ABCSG-12, ZO-FAST and more ...
Gnant M, Eidtmann H. Crit Rev Oncol Hematol. 2010 Apr; 74 Suppl 1:S2-6.
Review Bisphosphonates for breast cancer: questions answered, questions remaining. [Hematol Oncol Clin North Am. 2...]
Review Bisphosphonates for breast cancer: questions answered, questions remaining.
Layman R, Olson K, Van Poznak C. Hematol Oncol Clin North Am. 2007 Apr; 21(2):341-67.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Bisphosphonates: beyond prevention of bone metastases.
Bisphosphonates: beyond prevention of bone metastases.
J Natl Cancer Inst. 2011 Dec 7 ;103(23):1728-9. Epub 2011 Oct 21 .

PubMed
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a...
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
J Natl Cancer Inst. 2011 Nov 16 ;103(22):1686-95. Epub 2011 Oct 21 .

PubMed
Racial differences in depression trajectories among older women: socioeconomic, ...
Racial differences in depression trajectories among older women: socioeconomic, family, and health influences.
J Health Soc Behav. 2011 Dec ;52(4):444-59. Epub 2011 Oct 21 .

PubMed
An overview of the genetic susceptibility to alcoholism.
An overview of the genetic susceptibility to alcoholism.
Med Sci Law. 2011 ;51 Suppl 1:S2-6.

PubMed
Quality assurance and nighthawk radiology.
Quality assurance and nighthawk radiology.
AJR Am J Roentgenol. 2011 Nov ;197(5):W963.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Bisphosphonates: beyond prevention of bone metastases.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information